Your browser doesn't support javascript.
loading
Limited dsRNA editing impedes leukemia stem cells.
Pan, Yi; Kang, XunLei.
Afiliação
  • Pan Y; Division of Hematology and Oncology, Center for Precision Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA.
  • Kang X; Division of Hematology and Oncology, Center for Precision Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA; Ellis Fischel Cancer Center at MU Health Care, University of Missouri, Columbia, MO 65212, USA. Electronic address: kangxu@health.missouri.edu.
Trends Cancer ; 10(4): 280-282, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38458943
ABSTRACT
Understanding the mechanisms underlying the generation and maintenance of leukemia stem cells (LSCs) is crucial for the development of effective therapies against T cell acute lymphoblastic leukemia (T-ALL). In a recent study, Rivera et al. discovered that elevated adenosine deaminase acting on RNA (ADAR)-1-mediated RNA editing is a distinguishing feature of T-ALL relapse, and that ADAR1 suppresses apoptosis triggered by the double-stranded (ds)RNA-sensing pathway.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos